The FDA has approved deutetrabenazine extended-release tablets, a new once-daily formulation of the drug for adults with tardive dyskinesia or chorea associated with Huntington disease.
"For some patients living with TD and HD, treatment adherence can be a challenge that this new once-daily dosing option can help to address," Eric Hughes, MD, PhD, executive vice president of research and development and chief medical officer at Teva, said in a news release announcing the approval.
According to the company, the new once-daily formulation of deutetrabenazine has been shown to be therapeutically equivalent to the twice-daily formulation. It will be available in three extended-release tablet strengths: 6 mg, 12 mg, and 24 mg ― to be can be taken with or without food.TD is a debilitating and often irreversible movement disorder characterized by repetitive and uncontrollable movements of the tongue, lips, face, trunk, and extremities. The condition affects roughly 500,000 people in the United States and is caused by certain medications used to treat psychiatric disorders or gastrointestinal conditions.
HD affects more than 35,000 US individuals. About 90% of these patients experience chorea, which includes involuntary, nonrhythmic movements that appear to flow from one muscle to another.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Memorial plaque unveiled to honor Huntington Beach police officer killed in helicopter crashOfficials unveiled a plaque at Marina Park to commemorate the first anniversary of the death of Huntington Beach Police Officer Nicholas Vella, who was killed in a helicopter crash while patrolling over Newport Beach.
Read more »
Huntington Beach officer killed in helicopter crash honored with plaque at beach where he diedNicholas Vella was killed in a helicopter crash off the coast of Newport Beach one year ago Sunday.
Read more »
The FDA has recalled more than 300,000 bottles of Starbucks bottled FrappuccinosThe bottles of Starbucks' vanilla Frappuccinos may contain pieces of glass, the Food and Drug Administration said.
Read more »
FDA’s own reputation could be restraining its misinfo fightThe U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation
Read more »
FDA’s own reputation could be restraining its misinfo fightWASHINGTON (AP) — The government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations.
Read more »
FDA’s own reputation could be restraining its misinfo fightThe government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations. “Almost no one should be dying of COVID in the U.S. today,” Califf told The Associated Press, noting the government's distribution of free vaccines and antiviral medications.
Read more »